Literature DB >> 17575095

Prevalence of chronic obstructive pulmonary disease in China: a large, population-based survey.

Nanshan Zhong1, Chen Wang, Wanzhen Yao, Ping Chen, Jian Kang, Shaoguang Huang, Baoyuan Chen, Changzheng Wang, Diantao Ni, Yumin Zhou, Shengming Liu, Xiaoping Wang, Dali Wang, Jiachun Lu, Jingping Zheng, Pixin Ran.   

Abstract

RATIONALE: The prevalence of chronic obstructive pulmonary disease (COPD) in China is largely unknown.
OBJECTIVES: To obtain the COPD prevalence in China through a large-population, spirometry-based, cross-sectional survey of COPD.
METHODS: Urban and rural population-based cluster samples were randomly selected from seven provinces/cities. All residents 40 years of age or older in the selected clusters were interviewed with a standardized questionnaire revised from the international BOLD (Burden of Obstructive Lung Diseases) study. Spirometry was performed on all eligible participants. Patients with airflow limitation (FEV(1)/FVC < 0.70) were further examined by post-bronchodilator spirometry, chest radiograph, and electrocardiogram. Post-bronchodilator FEV(1)/FVC of less than 70% was defined as the diagnostic criterion of COPD.
MEASUREMENTS AND MAIN RESULTS: Among 25,627 sampling subjects, 20,245 participants completed the questionnaire and spirometry (response rate, 79.0%). The overall prevalence of COPD was 8.2% (men, 12.4%; women, 5.1%). The prevalence of COPD was significantly higher in rural residents, elderly patients, smokers, in those with lower body mass index, less education, and poor ventilation in the kitchen, in those who were exposed to occupational dusts or biomass fuels, and in those with pulmonary problems in childhood and family history of pulmonary diseases. Among the patients who had COPD, 35.3% were asymptomatic; only 35.1% reported lifetime diagnosis of bronchitis, emphysema, or other COPD; and only 6.5% have been tested with spirometry.
CONCLUSIONS: COPD is prevalent in individuals 40 years of age or older in China.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17575095     DOI: 10.1164/rccm.200612-1749OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  271 in total

1.  The rise of a non-communicable disease epidemic.

Authors:  Lawrence Grouse
Journal:  J Thorac Dis       Date:  2012-06-01       Impact factor: 2.895

2.  What is the difference between FEV1 change in percentage predicted value and change over baseline in the assessment of bronchodilator responsiveness in patients with COPD?

Authors:  Wenhua Jian; Jinping Zheng; Yi Hu; Yin Li; Yi Gao; Jiaying An
Journal:  J Thorac Dis       Date:  2013-08       Impact factor: 2.895

3.  Chronic obstructive pulmonary disease in China: the potential role of indacaterol.

Authors:  Jinming Gao; Niyati Prasad
Journal:  J Thorac Dis       Date:  2013-08       Impact factor: 2.895

4.  Genome-wide association analysis of body mass in chronic obstructive pulmonary disease.

Authors:  Emily S Wan; Michael H Cho; Nadia Boutaoui; Barbara J Klanderman; Jody S Sylvia; John P Ziniti; Sungho Won; Christoph Lange; Sreekumar G Pillai; Wayne H Anderson; Xiangyang Kong; David A Lomas; Per S Bakke; Amund Gulsvik; Elizabeth A Regan; James R Murphy; Barry J Make; James D Crapo; Emiel F Wouters; Bartolome R Celli; Edwin K Silverman; Dawn L DeMeo
Journal:  Am J Respir Cell Mol Biol       Date:  2010-10-29       Impact factor: 6.914

5.  BMI is an independent risk factor for snoring in Chinese women aged over 30 years.

Authors:  Qing-Yun Li; Shao-Guang Huang; Min Li; Jia-Lin Liu; Huan-Ying Wan
Journal:  Sleep Breath       Date:  2008-12-10       Impact factor: 2.816

6.  Public health: Where there's smoke.

Authors:  Virginia Hughes
Journal:  Nature       Date:  2012-09-27       Impact factor: 49.962

7.  The role of Interleukin 15 in protein degradation in skeletal muscles in rats of chronic obstructive pulmonary disease.

Authors:  Zhaohui Liu; Wei Fan; Jinlong Chen; Zhike Liang; Lijun Guan
Journal:  Int J Clin Exp Med       Date:  2015-02-15

Review 8.  Global lung health: the colliding epidemics of tuberculosis, tobacco smoking, HIV and COPD.

Authors:  R N van Zyl Smit; M Pai; W W Yew; C C Leung; A Zumla; E D Bateman; K Dheda
Journal:  Eur Respir J       Date:  2010-01       Impact factor: 16.671

9.  Functional polymorphisms in NFκB1/IκBα predict risks of chronic obstructive pulmonary disease and lung cancer in Chinese.

Authors:  Dongsheng Huang; Lei Yang; Yehua Liu; Yumin Zhou; Yuan Guo; Mingan Pan; Yunnan Wang; Yigang Tan; Haibo Zhong; Min Hu; Wenju Lu; Weidong Ji; Jian Wang; Pixin Ran; Nanshan Zhong; Yifeng Zhou; Jiachun Lu
Journal:  Hum Genet       Date:  2013-01-16       Impact factor: 4.132

10.  Synergistic effects of temperature and humidity on the symptoms of COPD patients.

Authors:  Zhe Mu; Pei-Li Chen; Fu-Hai Geng; Lei Ren; Wen-Chao Gu; Jia-Yun Ma; Li Peng; Qing-Yun Li
Journal:  Int J Biometeorol       Date:  2017-05-31       Impact factor: 3.787

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.